Proteome Analysis of Human Follicular Thyroid Cancer Cells Exposed to the Random Positioning Machine. by Bauer, J. et al.
 International Journal of 
Molecular Sciences
Communication
Proteome Analysis of Human Follicular Thyroid
Cancer Cells Exposed to the Random
Positioning Machine
Johann Bauer 1,*, Sascha Kopp 2, Elisabeth Maria Schlagberger 1, Jirka Grosse 3,
Jayashree Sahana 4, Stefan Riwaldt 4, Markus Wehland 2, Ronald Luetzenberg 2,
Manfred Infanger 2 and Daniela Grimm 2,4
1 Max-Planck-Institute for Biochemistry, Scientific Information Services, 82152 Martinsried, Germany;
schlagberger@biochem.mpg.de
2 Clinic and Policlinic for Plastic, Aesthetic and Hand Surgery, Otto-von-Guericke-University,
39120 Magdeburg, Germany; sascha.kopp@med.ovgu.de (S.K.); markus.wehland@med.ovgu.de (M.W.);
ronald.luetzenberg@med.ovgu.de (R.L.); manfred.infanger@med.ovgu.de (M.I.); dgg@biomed.au.dk (D.G.)
3 Department of Nuclear Medicine, University Hospital, University of Regensburg, 95053 Regensburg,
Germany; jirka.grosse@klinik.uni-regensburg.de
4 Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark; jaysaha@biomed.au.dk (J.S.);
sr@biomed.au.dk (S.R.)
* Correspondence: jbauer@biochem.mpg.de; Tel.: +49-89-85783803; Fax: +49-89-141-7931
Academic Editor: Anthony Lemarié
Received: 26 October 2016; Accepted: 27 February 2017; Published: 3 March 2017
Abstract: Several years ago, we detected the formation of multicellular spheroids in experiments with
human thyroid cancer cells cultured on the Random Positioning Machine (RPM), a ground-based
model to simulate microgravity by continuously changing the orientation of samples. Since then,
we have studied cellular mechanisms triggering the cells to leave a monolayer and aggregate to
spheroids. Our work focused on spheroid-related changes in gene expression patterns, in protein
concentrations, and in factors secreted to the culture supernatant during the period when growth is
altered. We detected that factors inducing angiogenesis, the composition of integrins, the density of
the cell monolayer exposed to microgravity, the enhanced production of caveolin-1, and the nuclear
factor kappa B p65 could play a role during spheroid formation in thyroid cancer cells. In this
study, we performed a deep proteome analysis on FTC-133 thyroid cancer cells cultured under
conditions designed to encourage or discourage spheroid formation. The experiments revealed more
than 5900 proteins. Their evaluation confirmed and explained the observations mentioned above.
In addition, we learned that FTC-133 cells growing in monolayers or in spheroids after RPM-exposure
incorporate vinculin, paxillin, focal adhesion kinase 1, and adenine diphosphate (ADP)-ribosylation
factor 6 in different ways into the focal adhesion complex.
Keywords: cellular compartments; mass spectrometry; proteomics; pathway analysis; random
positioning machine
1. Introduction
Multicellular spheroids (MCS) are interesting models of cancer [1,2]. They resemble natural
tumors more than cell monolayers, but they are not as complex as those [3]. Spheroids may be
generated in various ways [1]. One example is their exposure to real (r-µg) and simulated microgravity
(s-µg) [3]. s-µg can be achieved by application of the Random Positioning Machine (RPM), a device
created to simulate microgravity on Earth. During RPM-exposure, human cells are oriented randomly
with respect to the gravity vector, so that cell sedimentation does not occur [3]. In addition, the RPM is
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an interesting tool for novel applications, such as three-dimensional cell culturing as well as tissue
engineering [3].
Technical characteristics for microgravity-dependent spheroid formation include the following:
matrices are not required, frictional forces are extremely low, and cell-cell contact is established
by cell surface features. Spheroid formation under microgravity in vitro includes a cell leaving
a two-dimensional monolayer and joining neighbor cells in a three-dimensional manner. This process
is supposed to mirror, in part, the change of a cancer cell’s kind of growth in vivo as it is observed
during metastasis [4]. Hence, knowing the detailed cellular changes of spheroid formation may
provide information about cellular events occurring during metastasis.
For more than a decade we have aimed to define the cellular mechanisms causing the transition
from two- to three-dimensional growth in cells cultured under r-µg or s-µg. Meanwhile, we know
that subconfluent cultures of FTC-133 thyroid cancer cells divide into two populations when they are
exposed to r-µg or s-µg [5,6]. One continues to grow adherently on the bottom of the culture dish
and the other one forms three-dimensional aggregates (spheroids), which detach from the surface of
the culture dish and float in the culture medium. Interestingly, FTC-133 cells do not form spheroids
when they are exposed to s-µg created by an RPM or r-µg during spaceflight after previously forming
confluent monolayers [7]. Under these conditions, all cells continue to grow within a monolayer,
independent of the gravitational force they are exposed to.
In order to gain more information about the molecular mechanisms causing this differential
growth behavior, we studied FTC-133 cells after encouraging or discouraging spheroid formation
in vitro [5–7]. The harvested samples were analyzed by applying microscopy, gene array technology,
quantitative real time-PCR, and Multi-Analyte Profiling with the aim to examine cell morphologies,
gene expression patterns, and proteins which could be associated with the transition from a two- to
a three-dimensional growth pattern [5,6,8,9]. Taken together, these efforts revealed that exposure of
FTC-133 cells to microgravity enhances apoptosis and promotes nuclear factor kappa B (NFκB) p65
activities, while the caveolin 1 (CAV-1) gene is down-regulated during spheroid formation [6,10–12].
Most interestingly, several factors triggering angiogenesis were found in supernatants of thyroid
cells exposed to the RPM [8]. In addition, Western blotting and mass spectrometry (MS) experiments
revealed increased concentrations of several proteins, including vinculin, during growth on the RPM,
while caveolin-1 proteins were enriched in confluent FTC-133 cultures which do not form spheroids,
even if incubated on a RPM [7,12].
In this study, we applied advanced MS [13] and analyzed cells harvested after growth under five
distinct conditions, as shown in Table 1. The proteins detected were assigned to their original cell
compartments and the canonical pathways, wherein they are active, were assigned using modern
computer programs. Thereby, we recognized that different proteins regulating the structure of the focal
adhesion complexes were detectable in spheroid forming cells compared to cells that continued an
adherent growth under equal conditions. The results challenged the conclusion that variable structures
of the cell adhesion complex determine whether the cell leaves or perseveres in a given cell monolayer.
Table 1. Cell preparation and number of proteins detected.
Culture Condition 1 2 and 3 4 5 and 6
Sample Number #1 #2 #3 #4 #5
Pre-incubation 2 days 2 days 5 days 5 days
Following 3 days incubation under . . . 1g s-µg 1g s-µg
Kind of growth at time of harvest Adherent Spheroid Adherent Adherent Adherent
Number of proteins detected 4419 4505 4544 4621 4961
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2. Results and Discussion
2.1. Spheroid Formation
In the present study, three flasks completely filled with cell suspension were incubated under
each of the different culture conditions shown in Table 1. At the time of harvest, cells grown according
to culture conditions 1, 4, 5, and 6 had formed monolayers only, while cells incubated under culture
conditions 2 and 3 were separated into two parts: one grew as spheroids; the other one within adherent
monolayers (Table 1). Hence, by these in vitro experiments, we reproduced earlier studies where
FTC-133 thyroid cancer cells formed monolayers in plastic flasks if incubated under normal gravity.
When subconfluent monolayers of this cell type were exposed to a spaceflight or to an RPM, one part
of their cells formed spheroids [5,6]. Interestingly, spheroid formation did not occur when confluent
monolayers were grown on the RPM or in space [7]. After harvest, the cells of three flasks of the same
condition were pooled. This way, we obtained five samples (Table 1) usable for mass spectrometry
(MS). Sample 1 contained cells grown in a monolayer, cultured under culture condition 1. Sample 2
included cells that formed spheroids under culture conditions 2 and 3, sample 3 was comprised of
cells grown adherently under culture conditions 2 and 3. Sample 4 contained cells cultured under
culture condition 4 and grown in a monolayer, as well as sample 5, which comprised cells grown as
a monolayer only, although the cells had been cultured on the RPM (see culture conditions 5 and 6).
As no spheroids were found when confluent monolayers were exposed to the RPM, a sample 6 could
not be collected. All the samples were flash frozen immediately after harvest and stored until their
preparation for MS.
2.2. Quantitative Overview on Proteins Detected by Mass Spectrometry
In order to see possible differences in the protein expression of the FTC-133 cells cultured
under different conditions, MS was performed on the cell preparations of each of the five samples
indicated above. The analyses revealed a total of 5924 different human proteins in FTC-133 cells.
Of those, 3841 proteins were detected in all cells, independent of their incubation history. A total
of 4419, 4505, 4544, 4621, and 4961 proteins were found in samples 1, 2, 3, 4, and 5, respectively
(Table 1). Hence, applying modern electrospray ionization (ESI) MS technology we found much
more than the 821 different proteins which we had detected about eight years ago when we applied
matrix-assisted laser desorption/ionization (MALDI) technology after protein pre-separation with the
help of electrophoretic techniques [14,15]. Interestingly, we confirmed more than 95% of the proteins,
which had been detected previously in the examined thyroid cell lines FTC-133, ML-1, CGTH-W1, and
HTU-5. Of the 35 proteins detected previously but not in the current experiment, 22 were present in
ML-1, HTU-5, or CTGH-W1 cells, but only 15 were detectable in FTC-133 eight years ago. The first
result might be explained by differences in the protein patterns in different thyroid cell lines. The second
result could be due to a shift of isoforms as carbonic anhydrase 12, secernin 1, and high mobility group
protein 1-like 10 appeared now instead of carbonic anhydrase 13, secernin 2, and high mobility group
protein 1-like 1. However, it could also be due to the pre-separation procedure performed earlier as, for
example, most of these proteins had either a rather high or low isoelectric point [16].
In order to gain information about the biological roles of the proteins detected by MS, we
assigned the detected FTC-133 proteins to their original cellular compartments using Elsevier Pathway
Studio®software. The analysis revealed that the coverage of major cellular compartments by the
detected proteins was very similar in all cells treated by the different incubation methods. For example,
100% of all proteins typical for large ribosomal subunits and 93% of proteins characteristic for small
ribosomal proteins were found in all five samples, while on average 27.6%, 30.2%, and 29.6% of
known human membrane, cytoplasmic, and nuclear proteins, respectively, were detected (Table 2).
Furthermore, less than 21% of proteins normally secreted into the extracellular space were detected
in each sample. This may be explained by the washing of the cell samples prior to protein analysis.
However, proteins of other cellular components such as mitochondria, endoplasmic reticulum, and
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nucleolus were found at average rates of 48.8%, 36.8%, and 49.8%, respectively, and of the focal
adhesion complexes at 65% (Table 2). Comparing the numbers of Tables 1 and 2, one may suggest
that MS revealed around 40% of the proteins that can be found in the human cell proteome [13].
Of course, a protein not detected in our study does not directly imply that the protein is not expressed
in FTC-133 cells.
Table 2. Percentage of proteins of cellular compartments covered by the detected proteins.
Cellular Compartment Sample 1 Sample 2 Sample 3 Sample 4 Sample 5
Secreted proteins 19% 19% 19% 20% 21%
Membrane 27% 27% 27% 28% 29%
Nucleus 29% 29% 29% 30% 31%
Cytoplasm 29% 30% 30% 30% 32%
Golgi apparatus 31% 31% 32% 34% 35%
Cytoskeleton 33% 33% 34% 35% 37%
Endoplasmic reticulum membrane 35% 36% 37% 36% 39%
Endoplasmic reticulum 36% 36% 37% 36% 39%
Perinuclear region of cytoplasm 37% 38% 37% 38% 40%
Intracellular-membrane-bounded organelle 37% 37% 38% 39% 40%
Endosome 38% 38% 38% 40% 41%
Cytosol 38% 39% 39% 40% 42%
Extracellular exosome 41% 43% 42% 44% 45%
Nucleoplasm 42% 42% 42% 42% 45%
Mitochondrion 49% 48% 49% 48% 50%
Nucleolus 50% 50% 50% 49% 50%
Nuclear speck 51% 50% 50% 50% 57%
Mitochondrial inner membrane 60% 60% 61% 61% 62%
Focal adhesion 63% 64% 65% 65% 68%
Mitochondrial matrix 65% 62% 63% 65% 63%
Spliceosomal complex 68% 69% 66% 66% 71%
Ribonucleoprotein complex 72% 72% 71% 72% 73%
Mitochondrial small ribosomal subunit 93% 93% 93% 93% 93%
Large ribosomal subunit 100% 100% 100% 100% 100%
2.3. Coverage of Different Canonical Pathways by the Proteins Detected in Different Cell Samples
In further experiments, we sought information about the signaling behavior of the detected
proteins by applying Ingenuity Pathway Analysis (IPA). This in silico method revealed 478 canonical
pathways, in which the detected proteins covered at least 20% of the pathways’ proteins. A total of
229 of the indicated pathways comprised more than 20 contributing proteins. First, we took a closer
look at pathways including caveolin 1 (CAV-1), which according to earlier results appears to inhibit
spheroid formation [3,7]. This protein was detected by Western blotting (Figure 1). In MS measurement,
it showed Label-free Quantitation (LfQ) values of 6.47 × 109, 5.35 × 109, 9.25 × 109, 12.57 × 109, and
12.86 × 109 in samples 1, 2, 3, 4, and 5, respectively. The numbers clearly indicated that the spheroid
forming cells (sample 2) produced less CAV-1 proteins than the controls (sample 1), while in samples
3–5 the cells produced more CAV-1. This result corresponds to the gene analyses described in [6,11].
It was partially confirmed by Western blot analysis shown in Figure 1C.
CAV-1 was found as a member of the following pathways: caveolar-mediated endocytosis
signaling, endothelial nitric oxide synthase (eNOS) signaling, G beta gamma signaling, gap junction
signaling, Gαi signaling, integrin signaling, nitric oxide signaling in the cardiovascular system,
platelet-derived growth factor (PDGF) signaling, and virus entry via endocytosis. It is not known via
which one of these pathways CAV-1 exerts its inhibition of spheroid formation. Therefore, based on
earlier studies [17,18], we examined the proteins detected in samples 2 and 3 that are known to be
members of the integrin signaling pathway first.
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Figure 1. Western blot analyses and densitometric evaluation of FTC-133 cells exposed to culture 
conditions 1–5, normalized to the total protein content: (A) The c-Jun N-terminal kinase 1 (JNK-1) 
protein was not significantly altered when subconfluent monolayers were exposed to the Random 
Positioning Machine (RPM) for 3 days (d). JNK-1 was significantly reduced in adherent cells (AD) 
from culture condition 5 compared to that of the 1g-condition; (B) Vinculin was reduced in cells of 
multicellular spheroids (MCS) compared to that of AD (culture condition 3), and in AD 1g compared 
to that in AD (culture condition 3); (C) Caveolin 1 (Cav-1) protein was significantly reduced in MCS 
compared to that with 1g and AD (RPM); (D) Nuclear factor kappa B (NFκB) p65 protein was 
significantly decreased in the AD-RPM samples compared to that of the corresponding 1g-condition 
(culture condition 4); (E) Focal adhesion kinase 1 (FAK-1 also known as protein tyrosine kinase 2 or 
PTK2) protein was elevated in the AD of culture condition 5 compared to that in 1g; (F) 
Glycerinaldehyd-3-phosphat-Dehydrogenase (GAPDH) densitometric evaluation, normalized to the 
total protein content (Ponceau S red stain); (G) Western blot bands. * p < 0.05; n = 5 samples per 
group. 
According to the IPA tool, the integrin signaling pathway comprises 207 proteins. We detected 
98 and 102 of them in cells which grew in spheroids (sample 2) or monolayers (sample 3), 
respectively, although they had been subjected to equal conditions (see Table 1: culture condition 2 
and 3) within the same flask. Amongst them were a considerable number of various types of 
membrane proteins including integrins, which had not been removed from the cells during the 
various wash steps. To our surprise, nuclear proteins linked to the integrin signaling pathways were 
not detected (Figure 2). Studying the 98 and 102 proteins mentioned above in detail, we found that 
96 of the proteins detected in samples 2 and 3 and belonging to the integrin signaling pathway were 
identical. Only two of the 98 proteins of sample 2 and six of the 102 proteins of sample 3 were unique 
(Figure 2). 
Figure 1. Western blot analyses and densitometric evaluation of FTC-133 cells exposed to culture
conditions 1–5, normalized to the total protein content: (A) The c-Jun N-terminal kinase 1 (JNK-1)
protein was not significantly altered when subconfluent monolayers were exposed to the Random
Positioning Machine (RPM) for 3 days (d). JNK-1 was significantly reduced in adherent cells
(AD) from culture condition 5 compared to that of the 1g-condition; (B) Vinculin was reduced in
cells of multicellular spheroids (MCS) compared to that of AD (culture condition 3), and in AD
1g compared to that in AD (culture condition 3); (C) Caveolin 1 (Cav-1) protein was significantly
reduced in MCS compared to that with 1g and AD (RPM); (D) Nuclear factor kappa B (NFκB) p65
protein was significantly decreased in the AD-RPM samples compared to that of the corresponding
1g-condition (culture condition 4); (E) Focal adhesion kinase 1 (FAK-1 also known as protein tyrosine
kinase 2 or PTK2) protein was elevated in the AD of culture condition 5 compared to that in 1g;
(F) Glycerinaldehyd-3-phosphat-Dehydrogenase (GAPDH) densitometric evaluation, normalized to
the total protein content (Ponceau S red stain); (G) Western blot bands. * p < 0.05; n = 5 samples
per group.
According to the IPA tool, the integrin signaling pathway comprises 207 proteins. We detected 98
and 102 of them in cells which grew in spheroids (sample 2) or monolayers (sample 3), respectively,
although they had been subjected to equal conditions (see Table 1: culture condition 2 and 3) within
the same flask. Amongst them were a considerable number of various types of membrane proteins
including integrins, which had not been removed from the cells during the various wash steps. To our
surprise, nuclear proteins linked to the integrin signaling pathways were not detected (Figure 2).
Studying the 98 and 102 proteins mentioned above in detail, we found that 96 of the proteins detected
in samples 2 and 3 and belonging to the integrin signaling pathway were identical. Only two of the
98 proteins of sample 2 and six of the 102 proteins of sample 3 were unique (Figure 2).
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Figure 2. The interaction and localization of proteins belonging to the integrin signaling pathway 
and found in samples 2 and/or 3. The focal adhesion proteins paxillin (PXN), vinculin (VCL), PTK2 as 
well as ADB-ribosylation factor 6 (ARF6), marked by a green rim, may be influenced by the protein 
of ASAP1 (Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1), marked 
by a red rim, found only in sample 2 as well as by p130cas and Mitogen-activated protein kinase 8 
(MAPK8) proteins, marked by a blue rim, found only in sample 3. Arrows indicate interaction; 
schemes of a membrane bilayer, a nucleus (circle) and a mitochondrion outline localization. 
One of the proteins of the integrin pathway found only in sample 2 was the ASAP1 protein 
(Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1). As we 
demonstrated by Elsevier Pathway Studio® analysis, this protein interacts with several other 
proteins (Figure 2). Amongst them are vinculin (VCL), a rather abundant protein detectable by MS 
with an average LfQ of 11.82 × 109, and less abundant proteins such as paxillin (PXN) with an 
average LfQ value of 0.46 × 109, focal adhesion kinase 1 (PTK2, average LfQ = 0.72 × 109) as well as 
ADP-ribosylation factor 6 (ARF6, average LfQ = 0.6 × 109) (Figure 2). Their presence could be 
confirmed by Western blotting (Figure 1). ASAP1 regulates membrane traffic and cytoskeleton 
organization [19] and influences cell spreading and migration [20]. Directed by the Crk-like protein, 
it accumulates within the focal adhesion complex [21]. There, it co-localizes with PXN and VCL, 
which are able to bind to each other [19,22], and ASAP1 associates also with the focal adhesion 
kinase. Under unknown conditions, ASAP1 may cause a repositioning of PXN and focal adhesion 
kinase within the focal adhesion complex, which retards cell spreading [23]. ASAP1 has also been 
observed to bind to ARF6 [24]. This binding appears to facilitate the recruitment of ASAP1 to the 
focal adhesion complex [25]. Interestingly, the ASAP1 gene was up-regulated in adherent FTC-133 
cells after 24 h of incubation [11]. However, after 10 d in space, the ASAP1 gene was 7-fold 
down-regulated in adherent cells, while it remained unregulated in spheroid cells [5]. 
The p130cas and MAPK8 (Mitogen-activated protein kinase 8) protein, which both are members 
of the integrin signaling pathway, were detected in sample 3 but not in sample 2. The p130cas 
protein (see BCAR1, breast cancer anti-estrogen resistance protein 1, in Figure 2) interacts also with 
PXN, VCL, and PTK2. Paxillin is a membrane protein that regulates cell-matrix interaction, and 
associates with p130cas [26]. When PXN-p130cas complexes are phosphorylated, they constitutively 
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One of the proteins of the integrin pathway found only in sample 2 was the ASAP1 protein
(Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1). As we demonstrated
by Elsevier Pathway Studio® analysis, this protein interacts with several other proteins (Figure 2).
Amongst them are vinculin (VCL), a rather abundant protein detectable by MS with an average LfQ
of 11.82 × 109, and less abundant proteins such as paxillin (PXN) with an average LfQ value of
0.46 × 109, focal adhesion kinase 1 (PTK2, average LfQ = 0.72× 109) as well as ADP-ribosylation factor
6 (ARF6, average LfQ = 0.6 × 109) (Figure 2). Their presence could be confirmed by Western blotting
(Figure 1). ASAP1 regulates membrane traffic and cytoskeleton organization [19] and influences cell
spreading and migration [20]. Directed by the Crk-like protein, it accumulates within the focal adhesion
complex [21]. There, it co-localizes with PXN and VCL, which are able to bind to each other [19,22],
and ASAP1 associates also with the focal adhesion kinase. Under unknown conditions, ASAP1 may
cause a repositioning of PXN and focal adhesion kinase within the focal adhesion complex, which
retards cell spreading [23]. ASAP1 has also been observed to bind to ARF6 [24]. This binding appears
to facilitate the recruitment of ASAP1 to the focal adhesion complex [25]. Interestingly, the ASAP1
gene was up-regulated in adherent FTC-133 cells after 24 h of incubation [11]. However, after 10 d in
space, the ASAP1 gene was 7-fold down-regulated in adherent cells, while it remained unregulated in
spheroid cells [5].
The p130cas and MAPK8 (Mitogen-activated protein kinase 8) protein, which both are members
of the integrin signaling pathway, were detected in sample 3 but not in sample 2. The p130cas protein
(see BCAR1, breast cancer anti-estrogen resistance protein 1, in Figure 2) interacts also with PXN,
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VCL, and PTK2. Paxillin is a membrane protein that regulates cell-matrix interaction, and associates
with p130cas [26]. When PXN-p130cas complexes are phosphorylated, they constitutively activate cell
migration by inducing gene 5 proteins (RAC1) to abolish shear stress induced cell polarization [27].
Phosphorylation occurs by interaction with focal adhesion kinase after cell adhesion [28,29]. p130cas
interacts also with VCL in focal adhesion complexes that mediate cell-matrix interactions in the
presence of PXN [30,31]. MAPK8 proteins signal shear stress to focal adhesion sites in endothelial
cells [32]. Its activation is controlled by ARF6 [33]. In human multiple myeloma cells, the expression
of MAPK8 and interleukin-8 genes is suppressed simultaneously by azidothymidine [34]. Recently,
we found that MCF-7 breast cancer cells enhance interleukin-8 gene expression only in adherent cells
treated just as the cells of sample 3 [35]. In addition, when a population of FTC-133 was flown through
the orbit on a Chinese rocket (Shenzhou-8 space mission), the MAPK8 gene was up-regulated in the
cells remaining adherent. This suggested that a strengthening of the MAPK8 signal over extracellular
shear forces could hinder the cells to aggregate to floating spheroids. The conclusion has still to be
confirmed, as the c-Jun N-terminal kinase 1 (JNK-1), which is also called MAPK8, was, according to
Figure 1A, similar in MCS and adherent cells, both harvested from culture condition 2 and 3.
Taken together, the results shown in Figure 2 suggest that composition and interaction of PXN,
VCL, PTK2, and ARF6 are strongly influenced by ASAP1 when cells form spheroids (sample 2).
When FTC-133 cells grow in monolayers, even under conditions of microgravity (sample 3), the same
proteins are predominantly affected by p130cas and MAPK8. Enhanced ASAP1 appears to weaken the
focal adhesion complexes, so that the removal of sedimentation forces together with minimal shear
forces present in culture flasks on the RPM may trigger the cells to detach from the bottom of the
culture flask but anchor to neighboring cells [6,36]. At the same time, a predominance of p130cas
appears to strengthen lamellipodia [28] as well as cell-matrix interaction [30] via PXN [26], which
facilitates continued adherent growth.
Furthermore, we looked at the angiopoietin pathway. It comprises 66 proteins, 22 of which were
detected in sample 2. In sample 3, the 22 proteins of sample 2 were also found plus an additional seven
(Figure 3). Nineteen of the 29 proteins detected in samples 2 and 3 belong to both the angiopoietin
and the integrin signaling pathways. The finding of proteins of the angiopoietin pathway was not
surprising; we had repeatedly found increased gene expression and protein secretion of vascular
endothelial growth factor (VEGF) of the neutrophil gelatinase-associated lipocalin, osteopontin, and
the interleukins 6 and 17 in thyroid cancer cells, suggesting that factors of the angiopoietin pathway
may play a role in spheroid formation of FTC-133 cancer cells [5,8,37]. In this proteome study, no
membrane-bound receptor for VEGF or any other of the factors mentioned above could be detected
in the thyroid cells. Of the ten proteins belonging to the angiopoietin but not the integrin signaling
pathway, four proteins were found in sample 3 (adherent cells) but not in sample 2 (spheroids). One of
these was Ras GTPase-activating protein 1 (RASA1), which can bind to paxillin and to PTK2 and
supports cell migration and surface ruffling [38,39]. In addition, it forms a complex with survivin [40],
which accumulates CHUK protein (Inhibitor of nuclear factor kappa-B kinase subunit alpha) in the
nucleus [41]. There, CHUK protein together with IkBKB (Inhibitor of nuclear factor kappa-B kinase
subunit beta) regulates nuclear factor kappa B activity [11,42].
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Figure 3. The interaction and localization of proteins, belonging to the angiopoietin signaling 
pathway and found in samples 2 and/or 3. All proteins marked by a uniform green or blue rim were 
found in samples 2 and 3, while the proteins of CHUK, IKBKB, BIRC5, RAS1, PIK3R2, PAK1IP1 and 
AKT2, marked by a upper half red rim were found only in sample 3. Proteins of CHUK, IKBKB, 
BIRC5, RAS1, IKBKAP, IKBKG, PTPN11, NFKB1, NFKB2 and RELA belong to the angiopoietin 
pathway only. The rest of the proteins belong to the integrin signaling and the angiopoietin pathway 
simultaneously. Arrows indicate interaction, while T-bars show inhibition; schemes of a membrane 
bilayer, a nucleus (circle) and a mitochondrion outline localization. 
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Figure 3. The interaction and localization of proteins, belonging to the angiopoietin signaling pathway
and found in samples 2 and/or 3. All proteins marked by a uniform green or blue rim were found
in samples 2 and 3, while the proteins of CHUK, IKBKB, BIRC5, RAS1, PIK3R2, PAK1IP1 and AKT2,
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The rest of the proteins belong to the integrin signaling and the angiopoietin pathway simultaneously.
Arrows indicate interaction, while T-bars show inhibition; schemes of a membrane bilayer, a nucleus
(circle) and a mitochondrion outline localization.
3. Discussion
The proteome analysis of FTC-133 thyroid cancer cells cultured under various conditions revealed
more than 5900 proteins of this cell line. The proteins detected represent about 40% of proteins
possibly produced in human cells [13]. Their quantities ranged from 107 to 1011 LfQ values. Advanced
analysis of the detected proteins in regard to their association to the integrin signaling pathway and
the angiopoietin pathway challenged the following conclusions: In cells forming spheroids during
three d ys of cultur under s-µg, the lev ls of CAV-1 a d p130c s pr teins ar reduced, but ASAP1
producti n is enhanced. Under this condition, proteins PXN, VCL, a d PTK2 may be positi ned within
the focal adhesion co plex i a way that favors cell detachment fr m the bottom of a culture flask
and mutual attachment. The continuation of adherent growth could be supported by accumulation of
p130cas protein in individual cells. In order to prove this hypothesis, we shall investigate the structural
changes of the cell adhesion complex applying methods described recently [43].
4. Materials and Methods
4.1. Cell Culture
FTC-133 human follicular thyroid carcinoma cells [44] were cultured in RPMI 1640
(Life Technologies, Naerum, Denmark) medium supplemented with 10% fetal calf serum (Biochrom
AG, Berlin, Germany) and 1% penicillin/strepto yci (Life Technologies, Naerum, Denmark) under
standard cell culture conditions at 37 ◦C and 5% CO2. Prior to culturing under different conditions,
1 × 106 cells were counted and seeded i to T25 cm2 vented cell culture flasks (Sarstedt, Newton, MA,
USA). Twelve of these T25 cm2 culture flasks each containing 106 cells were incubated at 37 ◦C for two
days until the cells formed sub-confluent monolayers. Afterwards, three flasks were put nearby the
RPM (culture condition 1), while another three were mounted on the RPM (culture conditions 2 and 3).
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Then, each of these flasks was incubated for another three days prior to harvest. The six remaining
flasks continued to be cultured for another three days under normal gravity until the monolayers had
reached confluence. Then, again, three of the six flasks were put nearby the RPM (culture condition 4),
while the other three were mounted on the RPM (culture conditions 5 and 6). These flasks were also
incubated for another three days until harvest (Table 1). Therefore, the main difference between culture
conditions 1 and 4 as well as between culture conditions 2 and 3 and culture conditions 5 and 6 is the
length of the period of pre-incubation. These cell culture samples were used for MS. For the Western
blot analyses, we repeated these experiments (n = 5 per condition).
4.2. Random Positioning Machine
A desktop RPM (Airbus Defense and Space, Leiden, The Netherlands) was placed in a commercially
available incubator at 37 ◦C and 5% CO2. The RPM was used in real random mode with random speed
and random interval and a maximum speed of 75◦/s. The flasks were fixed to the central frame, as near
as possible to the center of rotation, and were rotated for 3 days. Corresponding static normal gravity
controls (1g) prepared in parallel were stored next to the device in the same incubator during the time
of rotation. Each flask was completely filled with complete medium, taking care that no air bubbles
remained in the cell culture flasks in order to minimize shear stress. The mode of action and the
effectiveness of this machine at preventing cell sedimentation have been described previously [45,46].
4.3. Cell Harvest
First, the supernatant of each T25 cm2 culture flask was collected and centrifuged at 4◦C
for spheroid collection. After centrifugation, the supernatant was carefully aspirated, and the
spheroids were collected, washed in phosphate buffered saline (PBS, Gibco, Life Technologies, Naerum,
Denmark), and stored in liquid nitrogen. To harvest the adherent cells, 5 mL of ice-cold PBS were
carefully added to each T25 cm2 flask. The supernatant was then aspirated and the cells were scraped
off with a scraper. The cell suspension was collected and centrifuged at 4 ◦C. The PBS was discarded
and the dry pellet was washed with PBS and stored in liquid nitrogen.
4.4. Mass Spectometry
Cells were lysed in a buffer containing 6 M guanidium hydrochloride, 20 mM TCEP
(tris(2-carboxyethyl)phosphine), and 40 mM chloroacetamide in 25 mM Tris pH 8.0. Lysis buffer,
preheated to 95 ◦C, was added to the cells and sonicated using a Bioruptor plus water bath sonicator
(Diagnode, Seraing, Belgium). The lysates were heated again at 95 ◦C for 2 min, followed by one more
sonication step at maximum power settings for ten cycles. Following complete lysis, the sample was
diluted 10-fold with 25 mM Tris pH 8.0 and digested overnight at 37 ◦C with endoproteinase Lys-C
(Wako Chemicals GmbH, Neuss, Germany) at a 1:50 protein ratio. The digested peptides were then
purified and concentrated on three plugged SDB-XC StageTip [47].
For the liquid chromatography-mass spectrometry analysis, about 2 µg of peptides were loaded onto a
15 cm, 75 µm I.D column packed with 1.9 µm C18 beads (Maisch GmbH, Ammerbuch, Germany) using the
Thermo easy n-LC 1000 system (Thermo Scientific, Waltham, MA, USA) and were separated over a 120-min
gradient with buffer A (0.1% formic acid) and buffer B (0.1% formic acid and 80% acetonitrile). The LC
(liquid chromatography) column was maintained at a constant temperature of 45 ◦C using a column oven
(Sonation, Biberach, Germany). The peptides eluting from the column were directly sprayed into a
Q Exactive HF mass spectrometer (Thermo Scientific, Waltham, MA, USA) via a nano-electrospray
ionization source (Thermo Scientific, Waltham, MA, USA) [48]. The mass spectrometer was operated
in a data-dependent top 15 mode. Survey scans and fragmentation scans were acquired at resolutions
of 60,000 and 15,000 respectively (m/z = 200). Fragmentation was performed on precursors isolated
within a window of 1.4 m/z with a normalized collision energy setting of 27.
Raw data from the mass spectrometer were processed using MaxQuant computational proteomics
platform version 1.5.2.22 (Computational Systems Biochemistry, Max-Planck-Gesellschaft, Munich,
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Germany) [49] using the standard parameters. Relative protein concentration was performed using
the LfQ algorithm (label-free quantitation) as described elsewhere [50].
4.5. Pathway Analysis
To investigate and visualize the original localization and the mutual interactions of detected
proteins, we entered relevant UniProtKB entry numbers in an Elsevier Pathway Studio®v.11 software
(Elsevier Research Solutions, Amsterdam, The Netherlands). To assign detected proteins to canonical
pathways, the Ingenuity Pathway Analysis (IPA) with Advanced Analytics client (CL) (Qiagen GmbH,
Hilden, Germany) was applied, also entering relevant UniProtKB entry numbers.
4.6. Western Blot
Western blotting, immunoblotting, and densitometry were performed as described earlier [17].
We used the biorad ChemiDoc XRT+ device. The antibodies used to detect and quantify the antigens
are listed in Table 3. The applied secondary antibody, a Horseradish peroxidase (HRP)-linked antibody
was utilized at a dilution of 1:4000 (Cell Signaling Technology, Inc., Danvers, MA, USA). In addition,
we used glyceraldehyde 3-phosphate dehydrogenase (GAPDH; dilution: 1:1000). Ponceau S red
staining was used as an alternative to housekeeping proteins as loading controls. The membranes
were analyzed using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA;
http://rsb.info.nih.gov/ij/), for densitrometric quantification of the bands. Ponceau S was evaluated
according to [51]. Statistical analyses were performed as previously published [17].
Table 3. Antibodies applied for Western blot analysis.
Antibody Dilution Company Molecular Weight Catalog Number
Anti-JNK1 1/1000 Abcam 48 kDA ab110724
Anti-FAK 1/1000 Abcam 125 KDA (119 kDA) ab40794
Anti-Vinculin 1/1000 Abcam 130 kDA ab18058
Anti-Caveolin-1 1/1000 Abcam 22 kDA ab2910
Anti-NfκB p65 1/1000 Cell-Signaling 65 kDA #C22B4
Anti-GAPDH 1/1000 Cell-Signaling 37 kDA #5174
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Abbreviations
AD Adherent cells
AKT1 RAC-alpha serine/threonine-protein kinase 1
ARF6 ADP-ribosylation factor 6
ASAP1 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1
BIRC5 Baculoviral inhibitor of apoptosis repeat-containing 5; Survivin
CAV-1 Caveolin 1
CHUK
Conserved helix-loop-helix ubiquitous kinase; Inhibitor of nuclear factor kappa-B
kinase subunit alpha (IKK-α)
GAPDH Glycerinaldehyd-3-phosphat-Dehydrogenase
HRP Horseradish peroxidase
IKBKB Inhibitor of nuclear factor kappa-B kinase subunit beta
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JNK1 c-Jun N-terminal kinase 1 or Mitogen-activated protein kinase 8
LfQ Label-free Quantitation
MAPK8 Mitogen-activated protein kinase 8
MCS Multicellular tumor spheroids
MS Mass Spectrometry
NFκB Nuclear factor kappa B
PAK1IP1 P21-activated protein kinase-interacting protein 1
PIK3R2 Phosphoinositide-3-kinase regulatory subunit 2
PTK2 Protein tyrosine kinase 2, focal adhesion kinase 1 (FAK1)
PXN Paxillin
Ras1 Ras-like protein 1
r-µg Real microgravity
RPM Random positioning machine
s-µg Simulated microgravity
VCL Vinculin
VEGF Vascular endothelial growth factor
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